Literature DB >> 19269866

Identification and molecular characterization of four new large deletions in the beta-globin gene cluster.

Philippe Joly1, Philippe Lacan, Caroline Garcia, Nicole Couprie, Alain Francina.   

Abstract

Despite the fact that mutations in the human beta-globin gene cluster are essentially point mutations, a significant number of large deletions have also been described. We present here four new large deletions in the beta-globin gene cluster that have been identified on patients displaying an atypical hemoglobin phenotype (high HbF) at routine analysis. The first deletion, which spreads over 2.0 kb, removes the entire beta-globin gene, including its promoter, and is associated with a typical beta-thal minor phenotype. The three other deletions are larger (19.7 to 23.9 kb) and remove both the delta and beta-globin genes. Phenotypically, they look like an HPFH-deletion as they are associated with normal hematological parameters. The precise localization of their 5' and 3' breakpoints gives new insights about the differences between HPFH and (deltabeta)(0)-thalassemia at the molecular level. The importance of detection of these deletions in prenatal diagnosis and newborn screening of hemoglobinopathies is also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269866     DOI: 10.1016/j.bcmd.2009.01.017

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

1.  A novel telomeric (approximately 285 kb) α-thalassemia deletion leading to a phenotypically unusual HbH disease.

Authors:  Philippe Joly; Philippe Lacan; Audrey Labalme; Elodie Bonhomme; Damien Sanlaville; Alain Francina
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

2.  Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.

Authors:  Elyes Slim Ghedira; Laure Lecerf; Emmanuelle Faubert; Bruno Costes; Kamran Moradkhani; Dora Bachir; Frédéric Galactéros; Serge Pissard
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

Review 3.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

4.  Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies.

Authors:  Selami Demirci; Alexis Leonard; John F Tisdale
Journal:  Hum Mol Genet       Date:  2020-09-30       Impact factor: 6.150

5.  A functional element necessary for fetal hemoglobin silencing.

Authors:  Vijay G Sankaran; Jian Xu; Rachel Byron; Harvey A Greisman; Chris Fisher; David J Weatherall; Daniel E Sabath; Mark Groudine; Stuart H Orkin; Anuja Premawardhena; M A Bender
Journal:  N Engl J Med       Date:  2011-09-01       Impact factor: 91.245

6.  Gap-PCR Screening for Common Large Deletional Mutations of β-Globin Gene Cluster Revealed a Higher Prevalence of the Turkish Inversion/Deletion (δβ)0 Mutation in Antalya.

Authors:  Türker Bilgen; Özden Altıok Clark; Zeynep Öztürk; M Akif Yeşilipek; İbrahim Keser
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Investigation of molecular heterogeneity of β-thalassemia disorder in District Charsadda of Pakistan.

Authors:  Muhammad Shakeel; Muhammad Arif; Shoaib Ur Rehman; Tabassum Yaseen
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.